The GPhA's Biosimilars Council cautions FDA against adopting distinguishable names for biosimilars and biologics.
Animal testing of cosmetic products and ingredients, and the sale of newly animal-tested cosmetics, would be phased out under legislation introduced in the U.S. House of Representatives.
Oregon Governor Kate Brown signed a piece of legislation earlier this month that helps expand patient access to pharmacists' patient care services.
The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance.
For 12 years, the Council for Responsible Nutrition has been educating members of Congress on the value and benefit of a regulated supplement industry.
Federal regulations governing unmanned aircraft systems, or drones, will be in place by this time next year. Most retailers won’t be ready, but Amazon says it will be as soon as the feds are.
The FDA announced on Tuesday that it determined that partially hydrogenated oils, the primary dietary source of artificial trans fat in processed foods, are not generally recognized as safe for use in human food.
Sens. Richard Blumenthal, D-Conn., and Sen. Dick Durbin, D-Ill., proposed three amendments to the National Defense Authorization Act that would impact how the military addresses supplementation.
"As it stands now, TPP will make it harder for the U.S. generic industry to sell its products overseas," GPhA's Ralp Neas reported.
The Patient Access to Pharmacists’ Care Coalition, a group of more than 25 organizations representing patients, has released newspaper and radio advertisements calling for passage of the Pharmacy and Medically Underserved Areas Enhancement Act.